エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/07 | 2,630 | 2,671 | 2,604 | 2,626 | -15 | -0.6% | 15,600 |
2023/04/06 | 2,609 | 2,641 | 2,565 | 2,641 | +10 | +0.4% | 16,000 |
2023/04/05 | 2,650 | 2,672 | 2,611 | 2,631 | -52 | -1.9% | 24,800 |
2023/04/04 | 2,757 | 2,758 | 2,669 | 2,683 | -75 | -2.7% | 25,400 |
2023/04/03 | 2,801 | 2,828 | 2,747 | 2,758 | -2 | -0.1% | 27,200 |
2023/03/31 | 2,785 | 2,814 | 2,722 | 2,760 | -22 | -0.8% | 33,000 |
2023/03/30 | 2,742 | 2,814 | 2,741 | 2,782 | +40 | +1.5% | 26,100 |
2023/03/29 | 2,626 | 2,746 | 2,626 | 2,742 | +117 | +4.5% | 25,300 |
2023/03/28 | 2,685 | 2,685 | 2,621 | 2,625 | -68 | -2.5% | 15,300 |
2023/03/27 | 2,700 | 2,725 | 2,666 | 2,693 | +35 | +1.3% | 17,800 |
2023/03/24 | 2,640 | 2,670 | 2,606 | 2,658 | +48 | +1.8% | 14,600 |
2023/03/23 | 2,539 | 2,617 | 2,538 | 2,610 | +50 | +2% | 10,800 |
2023/03/22 | 2,574 | 2,592 | 2,537 | 2,560 | +75 | +3% | 13,000 |
2023/03/20 | 2,586 | 2,586 | 2,485 | 2,485 | -95 | -3.7% | 15,900 |
2023/03/17 | 2,449 | 2,580 | 2,447 | 2,580 | +157 | +6.5% | 22,300 |
2023/03/16 | 2,402 | 2,442 | 2,399 | 2,423 | -33 | -1.3% | 21,100 |
2023/03/15 | 2,473 | 2,499 | 2,434 | 2,456 | +15 | +0.6% | 14,200 |
2023/03/14 | 2,452 | 2,494 | 2,424 | 2,441 | -51 | -2% | 22,900 |
2023/03/13 | 2,481 | 2,547 | 2,450 | 2,492 | -70 | -2.7% | 26,000 |
2023/03/10 | 2,600 | 2,600 | 2,561 | 2,562 | -72 | -2.7% | 14,700 |
2023/03/09 | 2,633 | 2,642 | 2,605 | 2,634 | +13 | +0.5% | 10,600 |
2023/03/08 | 2,607 | 2,628 | 2,570 | 2,621 | -4 | -0.2% | 9,200 |
2023/03/07 | 2,550 | 2,625 | 2,548 | 2,625 | +78 | +3.1% | 8,200 |
2023/03/06 | 2,580 | 2,581 | 2,540 | 2,547 | -13 | -0.5% | 11,400 |
2023/03/03 | 2,585 | 2,614 | 2,551 | 2,560 | -35 | -1.3% | 13,800 |
2023/03/02 | 2,571 | 2,599 | 2,559 | 2,595 | +9 | +0.3% | 11,500 |
2023/03/01 | 2,623 | 2,654 | 2,560 | 2,586 | -35 | -1.3% | 15,800 |
2023/02/28 | 2,574 | 2,662 | 2,574 | 2,621 | +53 | +2.1% | 29,200 |
2023/02/27 | 2,502 | 2,582 | 2,502 | 2,568 | +54 | +2.1% | 19,200 |
2023/02/24 | 2,500 | 2,530 | 2,446 | 2,514 | +29 | +1.2% | 19,100 |
2023/02/22 | 2,466 | 2,529 | 2,466 | 2,485 | -15 | -0.6% | 20,400 |
2023/02/21 | 2,478 | 2,518 | 2,452 | 2,500 | +22 | +0.9% | 24,100 |
2023/02/20 | 2,373 | 2,486 | 2,372 | 2,478 | +105 | +4.4% | 34,600 |
2023/02/17 | 2,398 | 2,398 | 2,331 | 2,373 | -31 | -1.3% | 25,900 |
2023/02/16 | 2,384 | 2,474 | 2,384 | 2,404 | +30 | +1.3% | 45,200 |
2023/02/15 | 2,558 | 2,570 | 2,321 | 2,374 | -184 | -7.2% | 149,600 |
2023/02/14 | 2,514 | 2,580 | 2,430 | 2,558 | +75 | +3% | 82,900 |
2023/02/13 | 2,732 | 2,750 | 2,482 | 2,483 | -499 | -16.7% | 233,700 |
2023/02/10 | 2,998 | 3,075 | 2,950 | 2,982 | +1 | ±0% | 67,700 |
2023/02/09 | 2,936 | 2,999 | 2,934 | 2,981 | +54 | +1.8% | 18,400 |
2023/02/08 | 2,864 | 2,934 | 2,864 | 2,927 | +63 | +2.2% | 16,000 |
2023/02/07 | 2,891 | 2,891 | 2,823 | 2,864 | -27 | -0.9% | 14,200 |
2023/02/06 | 2,855 | 2,908 | 2,855 | 2,891 | +53 | +1.9% | 12,300 |
2023/02/03 | 2,829 | 2,848 | 2,808 | 2,838 | -1 | ±0% | 8,600 |
2023/02/02 | 2,805 | 2,877 | 2,805 | 2,839 | +30 | +1.1% | 10,200 |
2023/02/01 | 2,813 | 2,864 | 2,806 | 2,809 | -1 | ±0% | 8,800 |
2023/01/31 | 2,896 | 2,896 | 2,804 | 2,810 | -70 | -2.4% | 13,400 |
2023/01/30 | 2,823 | 2,892 | 2,823 | 2,880 | +46 | +1.6% | 28,200 |
2023/01/27 | 2,861 | 2,935 | 2,817 | 2,834 | -9 | -0.3% | 21,400 |
2023/01/26 | 2,812 | 2,852 | 2,792 | 2,843 | +29 | +1% | 12,400 |
401~
450
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム